Six days after Netflix dropped all eight episodes of The WONDERfools simultaneously on May 15, 2026, the South Korean ...

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Data from Phase 1b dose escalation and expansion trial (n=69) shows a favorable safety profile, with manageable adverse events consistent with ...

Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...

UChicago’s partnership with the Massachusetts research institution—which will end next month after 13 years—offered valuable ...

Longevity, the length of human life, is the subject of growing scientific and commercial interest. Click here to read more.

The financing extends the Company's cash runway into the first quarter of 2028 and enables advancement of IMG-007 into a Phase 2 clinical trial in alopecia areata. IMG-007 is the leading ...

For more than two decades, B7-H3 sat on the shortlist of theoretically perfect cancer drug targets that nobody could quite figure out how to hit. The protein is broadly overexpressed across some of ...

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu for two new indications for patients with HER2-positive early breast cancer: Cambridge, UK Monday, May 18, 2026, 10:00 H ...

The Results Are In: Discover 100 Innovations in Skincare, Body Care, and Haircare, for Your 2026 Head-to-Toe Glow Up ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company ...